News

CENTOGENE weitet Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf den Frankfurter Flughafen aus

Nov 26, 2020

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 26. November 2020

Nach dem erfolgreichen Start des Angebots...

CENTOGENE Expands Express COVID-19 Antigen Testing to Frankfurt Airport

Nov 26, 2020

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 26, 2020

CENTOGENE's antigen tests are now available at...

CENTOGENE Expands Partnership with PTC Therapeutics to Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency

Nov 25, 2020

Expanded Partnership Provides Free Biochemical and Genetic Testing to Patients Enrolled in REVEAL CP Study and Expands...

CENTOGENE eröffnet Walk-In-COVID-19-Testzentrum in Wiesbadener Innenstadt

Nov 25, 2020

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 25. November 2020

Die zentrale Lage des Testzentrums...

CENTOGENE Announces Nomination of Jonathan Sheldon to Supervisory Board

Nov 13, 2020

CAMBRIDGE, Mass. And ROSTOCK, Germany and BERLIN, Nov. 13, 2020 (Globe Newswire) ─ CENTOGENE (Nasdaq: CNTG), a...

Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing

Nov 09, 2020

GENT, Belgium and CAMBRIDGE, Mass., USA, and ROSTOCK, Germany and BERLIN– November 9, 2020: Centogene N.V. (Nasdaq:...

CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testlösungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio

Nov 09, 2020

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 09. November 2020

Die Nachfrage nach flexiblen Lösungen für...

CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin Brandenburg Airport

Nov 05, 2020

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 05, 2020 (GLOBE NEWSWIRE)

CENTOGENE expands its SARS-CoV-2...

CENTOGENE eröffnet Walk-In-COVID-19-Testzentrum am Flughafen Berlin Brandenburg

Nov 05, 2020

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 05. November 2020

Nach erfolgreicher Inbetriebnahme von...

CENTOGENE gibt Führungswechsel bekannt

Oct 20, 2020

CAMBRIDGE, Mass. und ROSTOCK und BERLIN, Deutschland, 20. Oktober 2020 -

Centogene N.V. (Nasdaq: CNTG), ein...

1
2
3
....
19
Next

Press Contact

For further inquiries please contact:

Ben Legg

Corporate Communications

Send Email

Subscribe to our Newsletter

First Name

Last Name

Email *

Country

To receive the latest news and developments in clinical diagnostics and scientific breakthroughs in the rare disease field please click subscribe. After that, you will receive an email with a confirmation link. Once you have clicked on that link, we will inform you about our products, services and upcoming events per e-mail. You can unsubscribe from the newsletter with effect for the future at any time using the unsubscribe link contained in every newsletter.

Scientific articles

Defective mRNA Translation and Neurodegeneration

Based on their size and inability to renew, nerve cells are highly vulnerable to defects in many cellular processes, including the translation of mRNA. A recent study involving several researchers from CENTOGENE further…

Article Nov 24, 2020 with topic Neurology, WES, WGS, Mutation Database

Read more
Genetic Confirmation to Solidify Expert Clinical Suspicion

Expert physicians are able to clinically recognize even rare congenital conditions. In saying that, CENTOGENE still advises targeted genetic follow-up aimed at confirming the suspicion, as well as genetic counselling and…

Article Nov 22, 2020 with topic Dermatology, NGS

Read more
A Case Report with High Scientific Value

The value of a case report can be correlated with the rarity of the disorder it covers. A recent paper, which was triggered by a genetic diagnosis issued at CENTOGENE, is of rather high value in this respect. Published…

Article Nov 20, 2020 with topic Neurology, WGS, Mutation Database

Read more